Search Results - "M.-C. Potier"

Refine Results
  1. 1

    Classification of Human Chromosome 21 Gene-Expression Variations in Down Syndrome: Impact on Disease Phenotypes by Aït Yahya-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., Golfier, G., Rossier, J., Personnaz, L., Créau, N., Bléhaut, H., Robin, S., Delabar, J.M., Potier, M.-C.

    Published in American journal of human genetics (01-09-2007)
    “…Down syndrome caused by chromosome 21 trisomy is the most common genetic cause of mental retardation in humans. Disruption of the phenotype is thought to be…”
    Get full text
    Journal Article
  2. 2

    Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice by Braudeau, J, Delatour, B, Duchon, A, Pereira, P Lopes, Dauphinot, L, de Chaumont, F, Olivo-Marin, J-C, Dodd, RH, Hérault, Y, Potier, M-C

    Published in Journal of psychopharmacology (Oxford) (01-08-2011)
    “…An imbalance between inhibitory and excitatory neurotransmission has been proposed to contribute to altered brain function in individuals with Down syndrome…”
    Get full text
    Journal Article
  3. 3

    Integrating whole transcriptome assays on a lab-on-a-chip for single cell gene profiling by Bontoux, N, Dauphinot, L, Vitalis, T, Studer, V, Chen, Y, Rossier, J, Potier, M-C

    Published in Lab on a chip (01-01-2008)
    “…To correlate gene expression profiles to fundamental biological processes such as cell growth, differentiation and migration, it is essential to work at the…”
    Get more information
    Journal Article
  4. 4

    Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease by Janel, N, Alexopoulos, P, Badel, A, Lamari, F, Camproux, A C, Lagarde, J, Simon, S, Feraudet-Tarisse, C, Lamourette, P, Arbones, M, Paul, J L, Dubois, B, Potier, M C, Sarazin, M, Delabar, J M

    Published in Translational psychiatry (20-06-2017)
    “…Early identification of Alzheimer’s disease (AD) risk factors would aid development of interventions to delay the onset of dementia, but current biomarkers are…”
    Get full text
    Journal Article
  5. 5

    Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures by Schwaller, B, Tetko, I.V, Tandon, P, Silveira, D.C, Vreugdenhil, M, Henzi, T, Potier, M.-C, Celio, M.R, Villa, A.E.P

    Published in Molecular and cellular neuroscience (01-04-2004)
    “…Networks of GABAergic interneurons are of utmost importance in generating and promoting synchronous activity and are involved in producing coherent…”
    Get full text
    Journal Article
  6. 6

    Transmembrane protein 50b ( C21orf4 ), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brain by Moldrich, R.X, Lainé, J, Visel, A, Beart, P.M, Laffaire, J, Rossier, J, Potier, M.-C

    Published in Neuroscience (17-07-2008)
    “…Abstract Transmembrane protein 50b, Tmem50b , previously referred to as C21orf4 , encodes a predicted transmembrane protein and is one of few genes…”
    Get full text
    Journal Article
  7. 7

    The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome by Dauphinot, L., Lyle, R., Rivals, I., Dang, M. Tran, Moldrich, R.X., Golfier, G., Ettwiller, L., Toyama, K., Rossier, J., Personnaz, L., Antonarakis, S.E., Epstein, C.J., Sinet, P.-M., Potier, M.-C.

    Published in Human molecular genetics (01-02-2005)
    “…The central nervous system of persons with Down syndrome presents cytoarchitectural abnormalities that likely result from gene-dosage effects affecting the…”
    Get full text
    Journal Article
  8. 8

    Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post‐natal development by Potier, M.‐C., Rivals, I., Mercier, G., Ettwiller, L., Moldrich, R. X., Laffaire, J., Personnaz, L., Rossier, J., Dauphinot, L.

    Published in Journal of neurochemistry (01-04-2006)
    “…To understand the aetiology and the phenotypic severity of Down syndrome, we searched for transcriptional signatures in a substructure of the brain…”
    Get full text
    Journal Article Conference Proceeding
  9. 9
  10. 10

    Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer’s disease patients by Corlier, F, Rivals, I, Lagarde, J, Hamelin, L, Corne, H, Dauphinot, L, Ando, K, Cossec, J-C, Fontaine, G, Dorothée, G, Malaplate-Armand, C, Olivier, J-L, Dubois, B, Bottlaender, M, Duyckaerts, C, Sarazin, M, Potier, M-C

    Published in Translational psychiatry (07-07-2015)
    “…Identification of blood-based biomarkers of Alzheimer’s disease (AD) remains a challenge. Neuropathological studies have identified enlarged endosomes in…”
    Get full text
    Journal Article
  11. 11

    Selection of oligonucleotides for whole-genome microarrays with semi-automatic update by Golfier, G., Lemoine, S., van Miltenberg, A., Bendjoudi, A., Rossier, J., Le Crom, S., Potier, M.-C.

    Published in Bioinformatics (01-01-2009)
    “…Oligonucleotide microarray probes are designed to match specific transcripts present in databases that are regularly updated. As a consequence probes should be…”
    Get full text
    Journal Article
  12. 12

    VARAN: a web server for Variability Analysis of DNA microarray experiments by Golfier, G., Dang, M. Tran, Dauphinot, L., Graison, E., Rossier, J., Potier, M.-C.

    Published in Bioinformatics (01-07-2004)
    “…Here, we describe a tool for VARiability Analysis of DNA microarrays experiments (VARAN), a freely available Web server that performs a signal intensity based…”
    Get full text
    Journal Article
  13. 13

    Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain by Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., Crowther, R. A.

    Published in The EMBO journal (01-02-1989)
    “…We have isolated cDNA clones encoding a 383‐amino acid isoform of the human microtubule‐associated protein tau. It differs from previously determined tau…”
    Get full text
    Journal Article
  14. 14

    Transcription Profile Analysis Reveals That OBP-1F mRNA Is Downregulated in the Olfactory Mucosa Following Food Deprivation by Badonnel, K, Denis, J-B, Caillol, M, Monnerie, R, Piumi, F, Potier, M-C, Salesse, R, Baly, C

    Published in Chemical senses (01-09-2007)
    “…Neuroanatomical data show that olfactory mucosa (OM) is a possible place for interactions between nutrition and smell. A combination of differential display…”
    Get full text
    Journal Article
  15. 15

    HtrA1-dependent proteolysis of TGF-β controls both neuronal maturation and developmental survival by Launay, S, Maubert, E, Lebeurrier, N, Tennstaedt, A, Campioni, M, Docagne, F, Gabriel, C, Dauphinot, L, Potier, M C, Ehrmann, M, Baldi, A, Vivien, D

    Published in Cell death and differentiation (01-09-2008)
    “…Transforming growth factor- β (TGF- β ) signalling controls a number of cerebral functions and dysfunctions including synaptogenesis, amyloid- β accumulation,…”
    Get full text
    Journal Article
  16. 16

    Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells by Affaticati, P, Mignen, O, Jambou, F, Potier, M-C, Klingel-Schmitt, I, Degrouard, J, Peineau, S, Gouadon, E, Collingridge, G L, Liblau, R, Capiod, T, Cohen-Kaminsky, S

    Published in Cell death and differentiation (01-01-2011)
    “…L-glutamate, the major excitatory neurotransmitter, also has a role in non-neuronal tissues and modulates immune responses. Whether NMDA receptor (NMDAR)…”
    Get full text
    Journal Article
  17. 17

    The Human Myosin Light Chain Kinase (MLCK) from Hippocampus: Cloning, Sequencing, Expression, and Localization to 3qcen–q21 by POTIER, M.-C., CHELOT, E., PEKARSKY, Y., GARDINER, K., ROSSIER, J., TURNELL, W.G.

    Published in Genomics (San Diego, Calif.) (10-10-1995)
    “…Myosin light chain kinase (MLCK), a key enzyme in muscle contraction, has been shown by immunohistology to be present in neurons and glia. We describe here the…”
    Get full text
    Journal Article
  18. 18

    Innovative instrumentation for microarray scanning and analysis: application for characterization of oligonucleotide duplexes behavior by Khomyakova, E B, Dreval, E V, Tran-Dang, M, Potier, M C, Soussaline, F P

    Published in Cellular and Molecular Biology (01-05-2004)
    “…Accuracy in microarray technology requires new approaches to microarray reader development. A microarray reader system (optical scanning array or OSA reader)…”
    Get full text
    Journal Article
  19. 19

    Plasma DYRK1A as a novel risk factor for Alzheimer’s disease by Janel, N, Sarazin, M, Corlier, F, Corne, H, de Souza, L C, Hamelin, L, Aka, A, Lagarde, J, Blehaut, H, Hindié, V, Rain, J-C, Arbones, M L, Dubois, B, Potier, M C, Bottlaender, M, Delabar, J M

    Published in Translational psychiatry (12-08-2014)
    “…To determine whether apparent involvement of DYRK1A in Alzheimer’s disease (AD) pathology makes it a candidate plasma biomarker for diagnosis, we developed a…”
    Get full text
    Journal Article
  20. 20

    Bacterial contig map of the 21q11 region associated with Alzheimer's disease and abnormal myelopoiesis in Down syndrome by Groet, J, Ives, J H, South, A P, Baptista, P R, Jones, T A, Yaspo, M L, Lehrach, H, Potier, M C, Van Broeckhoven, C, Nizetić, D

    Published in Genome research (01-04-1998)
    “…We present a high-resolution bacterial contig map of 3.4 Mb of genomic DNA in human chromosome 21q11-q21, encompassing the region of elevated disomic…”
    Get full text
    Journal Article